The overall goal of The Sidney Kimmel Comprehensive Cancer Center (SKCCC) Cancer Molecular and Functional Imaging (CMFI) Program is to integrate molecular and functional imaging with translational applications in cancer discovery, drug development and treatment. The CMFI Program has been a developing Program of the Comprehensive Center Support Grant at the SKCCC for five years and has grown from ten to 25 faculty members representing five departments of the School of Medicine. Faculty members hold appointments in four different graduate programs. Twenty faculty members have peer reviewed funding. A majority of the faculty is housed in the CRBI/II complex and the Program is home to roughly ten graduate students and 15 Postdoctoral fellows. The Program is supported by $9.2 million of NCI and other peer reviewed support. The Program contains four highly integrated themes: 1) cancer biology and discovery;2) imaging probe development;3) biomarkers and clinical evaluation of therapies;and 4) target delineation and drug delivery, which are highly interactive with disease-based Programs within the SKCCC. The central goal of the CMFI Program is to use molecular and functional imaging in the diagnosis and treatment of cancer. A major goal of the clinical translational component involves the clinical evaluation of therapies and theranostic imaging. The Program has major interactions with the Breast Cancer, Prostate Cancer, Neuro-oncology, and Hematologic Malignancy/BMT Programs. The total number of publications in the CMFI Program from 2006-2010 is 296 of which 92 (31%) are Intra-Programmatic and 63 (21%) are Inter- Programmatic. Lay: The Cancer Molecular and Functional Imaging Program integrates molecular and functional imaging into cancer research to inform discovery and translational applications into diagnosis, therapy and drug development. The CMFI Program contains four highly integrated themes: 1) cancer biology and discovery;2) imaging probe development;3) biomarkers and clinical evaluation of therapies;and 4) target delineation and drug delivery, which are highly interactive with disease-based Programs within the SKCCC.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA006973-51
Application #
8661010
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2014-05-01
Budget End
2015-04-30
Support Year
51
Fiscal Year
2014
Total Cost
$199,755
Indirect Cost
$76,700
Name
Johns Hopkins University
Department
Type
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Zeidner, Joshua F; Zahurak, Marianna; Rosner, Gary L et al. (2015) The evolution of treatment strategies for patients with chronic myeloid leukemia relapsing after allogeneic bone marrow transplant: can tyrosine kinase inhibitors replace donor lymphocyte infusions? Leuk Lymphoma 56:128-34
Penet, Marie-France; Shah, Tariq; Bharti, Santosh et al. (2015) Metabolic imaging of pancreatic ductal adenocarcinoma detects altered choline metabolism. Clin Cancer Res 21:386-95
Sharabi, Andrew B; Nirschl, Christopher J; Kochel, Christina M et al. (2015) Stereotactic Radiation Therapy Augments Antigen-Specific PD-1-Mediated Antitumor Immune Responses via Cross-Presentation of Tumor Antigen. Cancer Immunol Res 3:345-55
Peltonen, Karita; Colis, Laureen; Liu, Hester et al. (2014) A targeting modality for destruction of RNA polymerase I that possesses anticancer activity. Cancer Cell 25:77-90
DeZern, Amy E; Guinan, Eva C (2014) Aplastic anemia in adolescents and young adults. Acta Haematol 132:331-9
Paller, Channing J; Wissing, Michel D; Mendonca, Janet et al. (2014) Combining the pan-aurora kinase inhibitor AMG 900 with histone deacetylase inhibitors enhances antitumor activity in prostate cancer. Cancer Med 3:1322-35
Maldonado, Leonel; Teague, Jessica E; Morrow, Matthew P et al. (2014) Intramuscular therapeutic vaccination targeting HPV16 induces T cell responses that localize in mucosal lesions. Sci Transl Med 6:221ra13
Schweizer, Michael T; Antonarakis, Emmanuel S (2014) Chemotherapy and its evolving role in the management of advanced prostate cancer. Asian J Androl 16:334-40
Huang, Peng; Ou, Ai-hua; Piantadosi, Steven et al. (2014) Formulating appropriate statistical hypotheses for treatment comparison in clinical trial design and analysis. Contemp Clin Trials 39:294-302
Bhatnagar, Akrita; Wang, Yuchuan; Mease, Ronnie C et al. (2014) AEG-1 promoter-mediated imaging of prostate cancer. Cancer Res 74:5772-81

Showing the most recent 10 out of 357 publications